Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 8, 1978 - Issue 9
10
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Metabolic Fate of 1-Hexylcarbamoyl-5-fluorouracil in Rats

, , , , , , , , & show all
Pages 547-556 | Received 10 Nov 1977, Published online: 30 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

T. Kobari, Y. Iguro, A. Ujiie & H. Namekawa. (1981) Metabolism of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a new antitumour agent, in rats, rabbits and dogs. Xenobiotica 11:1, pages 57-62.
Read now
M. Iigo, A. Nakamura, K. Kuretani & A. Hoshi. (1980) Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil after oral administration in mice. Xenobiotica 10:11, pages 847-854.
Read now

Articles from other publishers (19)

Mohammad Mohiminul Islam & Shama P. Mirza. (2022) Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacology. Drug Development Research 83:7, pages 1505-1518.
Crossref
Kangni Wu, Yanghui Xiu, Pan Zhou, Yan Qiu & Yuhang Li. (2019) A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities. Frontiers in Pharmacology 10.
Crossref
Natalia Realini, Carlos Solorzano, Chiara Pagliuca, Daniela Pizzirani, Andrea Armirotti, Rosaria Luciani, Maria Paola Costi, Tiziano Bandiera & Daniele Piomelli. (2013) Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Scientific Reports 3:1.
Crossref
H Ikehira, F Girard, T Obata, H Ito, H Yoshitomi, M Miyazaki, N Nakajima, H Kamei, Y Kanazawa, H Takano, H Ito, S Tanada & Y Sasaki. (1999) A preliminary study for clinical pharmacokinetics of oral fluorine anticancer medicines using the commercial MRI system 19F-MRS.. The British Journal of Radiology 72:858, pages 584-589.
Crossref
Keizo Sugimachi, Yoshihiko Maehara, Michio Ogawa, Teruo Kakegawa, Masao Tomita & Tsuyoshi Akiyoshi. (1996) Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection. Cancer 77:1, pages 36-43.
Crossref
Kenji Takenaka, Takashi Kanematsu, Mitsuo Shimada & Keizo Sugimachi. (1989) Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma. European Journal of Cancer and Clinical Oncology 25:8, pages 1191-1195.
Crossref
Riki Okeda, Makoto Shibutani, Takashi Matsuo & Toshihiko Kuroiwa. (1988) SUBACUTE NEUROTOXICITY OF 5-FLUOROURACIL and ITS DERIVATIVE, CARMOFUR, IN CATS. Pathology International 38:10, pages 1255-1266.
Crossref
Yoshihiko Maehara, Hiroki Kusumoto, Hideaki Anal, Tetsuya Kusumoto, Yoichiro Hiramoto & Keizo Sugimachi. (1987) 1-hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro. European Journal of Cancer and Clinical Oncology 23:10, pages 1511-1515.
Crossref
S. Kuzuhara, N. Ohkoshi, K. Kanemaru, H. Hashimoto, T. Nakanishi & Y. Toyokura. (1987) Subacute leucoencephalopathy induced by carmofur, a 5-fluorouracil derivative. Journal of Neurology 234:6, pages 365-370.
Crossref
Hitoshi Sasaki, Tohru Takahashi, Junzo Nakamura, Ryoji Konishi & Juichiro Shibasaki. (1986) Intestinal Absorption of 5-Fluorouracil and its Alkylcarbamoyl Derivatives in the Rat Small Intestine. Journal of Pharmaceutical Sciences 75:7, pages 676-679.
Crossref
Makoto Ogawa. 1985. Experimental and Clinical Progress in Cancer Chemotherapy. Experimental and Clinical Progress in Cancer Chemotherapy 133 140 .
Anthony F. Hadfield & Alan C. Sartorelli. 1984. 21 67 .
R. Okeda, T. Karakama, S. Kimura, S. Toizumi, T. Mitsushima & Y. Yokoyama. (1984) Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs. Acta Neuropathologica 63:4, pages 334-343.
Crossref
Osamu Nakajima, Yohko Yoshida, Takako Isoda, Yuhzo Takemasa, Yukio Imamura & Yoshiyuki Koyama. (1981) Quantitative determination of 1-hexylcarbamoyl-5-fluorouracil and its metabolites in man. Journal of Chromatography B: Biomedical Sciences and Applications 225:1, pages 91-97.
Crossref
Hiromi Isomura, Saburo Higuchi & Shigeo Kawamura. (1981) Gas chromatographic—mass spectrometric determination of plasma 5-fluorouracil after administration of 1-hexylcarbamoyl-5-fluorouracil to dogs and humans. Journal of Chromatography B: Biomedical Sciences and Applications 224:3, pages 423-429.
Crossref
. (1981) . Kanzo 22:6, pages 915-915.
Crossref
Y. Sakurai. 1981. New Drugs in Cancer Chemotherapy. New Drugs in Cancer Chemotherapy 91 99 .
Akira Kono, Yasuhiro Hara, Sanetomi Eguchi, Mutsuko Tanaka & Yoshikazu Matsushima. (1980) Determination of two new metabolites of 1-hexylcarbamoyl-5-fluorouracil in biomedical specimens by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 182:1, pages 125-129.
Crossref
Akira Kono, Mutsuko Tanaka, Sanetomi Eguchi, Yasuhiro Hara & Yoshikazu Matsushima. (1979) Determination of 1-hexylcarbamoyl-5-fluorouracil and its metabolites in biomedical specimens by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 163:1, pages 109-113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.